Results 221 to 230 of about 5,099,978 (377)

ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a cycle followed by every‐other‐week (Q2W) dosing.
Ali A. Habib   +16 more
wiley   +1 more source

The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Determine the association between diabetes and metabolic syndrome (MetS) burden (number of MetS criteria fulfilled) and pain, neuropathy severity, and fiber type involvement in individuals with established polyneuropathy. Methods The Peripheral Neuropathy Research Registry was queried for individuals with type 1 and type 2 diabetes ...
Long Davalos   +13 more
wiley   +1 more source

METHODICAL GUIDELINES FOR THE STRUGGLE AGAINST CHICKEN EIMERIOSIS IN FARMS AND PRIVATE SUBSIDIARY HOLDINGS

open access: yesРоссийский паразитологический журнал, 2016
The comprehensive data on the prevalence of chicken eimeriosis in farms and private holdings, types of causative agents, epizootological features, diagnostic methods, and struggle  measures with the use of modern preparations are presented. The extensive
P. V. Novikov, R. T. Safiullin
doaj  

An Analysis for IDH‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose There is ongoing debate regarding the therapeutic approach and prognosis for IDH‐mutant grade 4 astrocytoma, a newly defined subtype of diffuse glioma in the 2021 WHO classification system for central nervous system tumors (WHO CNS 5). The aim of this study was to explore the clinical outcome and prognosticators for newly diagnosed IDH‐
Xianxin Qiu   +13 more
wiley   +1 more source

ACTIVE TOLERANCE TO DONOR NON-HLA (“MINOR H”) ANTIGENS AFTER 27 YEARS OF DRUG-FREE, STABLE KIDNEY GRAFT SURVIVAL.

open access: bronze, 2000
William J. Burlingham   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy